VION Biosciences completes acquisition of BioAssay Systems to enhance product offering in life science research
Feb 05, 2025•10 months ago
Acquiring Company
VION Biosciences
Acquired Company
BioAssay Systems
Description
VION Biosciences, a life science platform company, has announced the acquisition of San Francisco area-based BioAssay Systems. This acquisition enhances VION’s proprietary product offering in the life science research field, strengthening its core strengths in drug discovery and research. The acquisition will provide reliable, high-quality solutions for critical research in the life science space and contributes to VION’s domestic and global expansion efforts.
M&A Insights
Based on deal dataIntegration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed